share_log

GlycoMimetics Shares Are Trading Higher After the Company Announced It Will Merge With Crescent Biopharma and Secured $200 in Funding to Advance Its Oncology Pipeline.

Benzinga ·  Oct 29, 2024 20:18
GlycoMimetics Shares Are Trading Higher After the Company Announced It Will Merge With Crescent Biopharma and Secured $200 in Funding to Advance Its Oncology Pipeline.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment